AB
CGEM icon

Amalgamated Bank’s Cullinan Oncology CGEM Stock Holding History

Amalgamated Bank’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,696
Closed -$18K – 1853
2025
Q4 		$18K Sell
1,696
-72
-4% -$649 ﹤0.01% 2149
2025
Q3 		$10K Hold
1,768
– – ﹤0.01% 2456
2025
Q2 		$13K Hold
1,768
– – ﹤0.01% 2302
2025
Q1 		$13K Hold
1,768
– – ﹤0.01% 2241
2024
Q4 		$22K Hold
1,768
– – ﹤0.01% 2078
2024
Q3 		$30K Buy
1,768
+872
+97% +$15.5K ﹤0.01% 1992
2024
Q2 		$16K Hold
896
– – ﹤0.01% 2207
2024
Q1 		$15K Sell
896
-1,274
-59% -$19.7K ﹤0.01% 2250
2023
Q4 		$22K Sell
2,170
-267
-11% -$2.37K ﹤0.01% 2597
2023
Q3 		$22K Hold
2,437
– – ﹤0.01% 2607
2023
Q2 		$26K Sell
2,437
-448
-16% -$4.76K ﹤0.01% 2605
2023
Q1 		$30K Sell
2,885
-986
-25% -$10.9K ﹤0.01% 2498
2022
Q4 		$41K Hold
3,871
– – ﹤0.01% 2504
2022
Q3 		$50K Buy
3,871
+82
+2% +$1.1K ﹤0.01% 2459
2022
Q2 		$49K Buy
3,789
+582
+18% +$6.6K ﹤0.01% 2491
2022
Q1 		$34K Buy
+3,207
New +$43.3K ﹤0.01% 2626

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Amalgamated Bank's CGEM Position: Q1 2026 in Review

Amalgamated Bank sold out of Cullinan Oncology (CGEM) in Q1 2026, closing a stake of 1,696 shares — an estimated $18K sold.

Amalgamated Bank first reported a position in CGEM in Q1 2022 and held it in 16 quarters. The position peaked at $50K in Q3 2022. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • Amalgamated Bank reported no remaining Cullinan Oncology position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,696 Cullinan Oncology shares in Q1 2026, an estimated $18K.
  • Amalgamated Bank first reported a position in Cullinan Oncology in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Cullinan Oncology position peaked at $50K in Q3 2022.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.